Abstract
Exposure in the central circulation is an essential prerequisite for efficacy and safety of systemic drugs. After oral administration the rate and extent of absorption from the gastrointestinal tract may be significantly determined by the biopharmaceutical properties of both, the drug substance as well as the drug formulation. This is the reason why rate and extent of bioavailability of oral dosage forms needs to be characterized thoroughly during drug product development for regulatory submission. In case of generic medicinal products assessment of bioequivalence in comparison to an appropriate reference product is the basis for marketing authorization applications and the approval process. The requirements for this procedure are therefore clearly defined in the bioequivalence guidelines published by the competent regulatory authorities, e.g. EMA in Europe or FDA in the USA.
Most relevant parameters to be considered in this context are discussed in this chapter. Since there are still certain differences between the main guidelines activities have been started to discuss the basis for science-driven regulations and to harmonize the existing requirements. In particular the Global Bioequivalence Harmonization Initiative (GBHI) of the European Federation for Pharmaceutical Sciences (EUFEPS) has achieved significant contributions to this process.
References and Further Reading
Amidon GL, Lennernäs H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413–420
Blume H, Midha KK (1993) Bio-international ‘92, conference on bioavailability/bioequivalence and pharmacokinetic studies. J Pharm Sci 82:1186–1189
Blume HH, Schug BS (1999) Class III drugs – better candidates for BA/BE waiver. Eur J Pharm Sci 9:117–121
Blume HH, McGilveray IJ, Midha KK (1995) BIO-international ‘94, conference report on bioavailability, bioequivalence and pharmacokinetic studies. Eur J Drug Metab Pharmacokinet 20:3–13
Chen M-L, Blume H, Beuerle G, Davit B, Mehta M, Potthast H, Schug B, Tsang YC, Wedemeyer R-S, Weitschies W, Welink J (2018) The global bioequivalence harmonization initiative: summary report for EUFEPS international conference. Eur J Pharm Sci 111:153–157
Chen M-L, Blume H, Beuerle G, Mehta M, Potthast H, Brandt A, Schug B, Ducharme M, Endrenyi L, Gallicano K, Schuirmann D, Welink J (2019) The global bioequivalence harmonization initiative: report of EUFEPS/AAPS second conference. Eur J Pharm Sci 127: 24–28
Karim A (1986) Effects of food on the bioavailability from controlled-release products in adults. J Allergy Clin Immunol 78:695–70
McGilveray IJ, Midha KK, Skelly JP, Dighe S, Doluisio JT, French IW, Karim A, Burford R (1990) Consensus report from bio international ‘89: issues in the evaluation of bioavailability data. J Pharm Sci 79:945–946
Midha KK, Nagai T, Blume HH, Hubbard JW, McGilveray IJ, Williams R (1996) Conference report of bio-international ‘96, conference on bioavailability, bioequivalence and pharmacokinetic studies
Midha KK, Shah VP, Singh GJP, Patnaik R (2005) Conference report: bio-international 2005. J Pharm Sci 96:747–754
Schug BS, Wolf D, Nilius R, Martin W, Schall R, Blume HH (2000) Product related food effects for nifedipine once daily solid oral dosage forms. Poster at the APVWorld Conference, Berlin
The global bioequivalence harmonization initiative: report of EUFEPS/AAPS third conference. Manuscript in preparation
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Blume, H.H. (2019). Bioequivalence. In: Hock, F., Gralinski, M. (eds) Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-56637-5_17-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56637-5_17-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56637-5
Online ISBN: 978-3-319-56637-5
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences